A Phase 2 study of HART in metastatic cancer

Recruiting Phase 2 NCT06778408

Study Description

Evaluating a new radiation therapy technique for reducing gastrointestinal side effects in patients with metastatic cancer

Study Details

Registry ID:
NCT06778408
Conditions:
Palliative Radiotherapy, Metastatic Cancer (Different Solid Tumour Types)
Phase:
Phase 2
Target Enrollment:
103 participants
Start Date:
Age Range:
18–999 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →